Tyra Biosciences, Inc. (NASDAQ:TYRA - Get Free Report) saw strong trading volume on Friday . 802,309 shares changed hands during mid-day trading, an increase of 190% from the previous session's volume of 276,558 shares.The stock last traded at $11.24 and had previously closed at $10.74.
Analyst Ratings Changes
A number of research analysts have recently weighed in on the company. HC Wainwright restated a "buy" rating and issued a $30.00 price target on shares of Tyra Biosciences in a research report on Tuesday, February 18th. UBS Group assumed coverage on Tyra Biosciences in a research report on Tuesday, January 7th. They issued a "buy" rating and a $28.00 price target for the company. Six equities research analysts have rated the stock with a buy rating, According to data from MarketBeat.com, the company has a consensus rating of "Buy" and an average target price of $30.50.
Read Our Latest Analysis on TYRA
Tyra Biosciences Stock Up 1.3 %
The firm has a market cap of $550.56 million, a price-to-earnings ratio of -6.76 and a beta of 1.09. The business has a 50 day moving average of $13.34 and a 200 day moving average of $16.91.
Insider Activity at Tyra Biosciences
In related news, Director Nina S. Kjellson sold 7,779 shares of the stock in a transaction on Thursday, January 16th. The stock was sold at an average price of $16.29, for a total transaction of $126,719.91. Following the sale, the director now owns 447,857 shares of the company's stock, valued at $7,295,590.53. This trade represents a 1.71 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Insiders have sold a total of 21,998 shares of company stock valued at $344,818 over the last quarter. Insiders own 15.40% of the company's stock.
Institutional Trading of Tyra Biosciences
A number of hedge funds have recently added to or reduced their stakes in the business. RA Capital Management L.P. boosted its stake in Tyra Biosciences by 2.1% in the 4th quarter. RA Capital Management L.P. now owns 10,637,290 shares of the company's stock worth $147,858,000 after buying an additional 220,681 shares during the last quarter. Alta Partners Management Company L.P. acquired a new stake in Tyra Biosciences in the 4th quarter worth about $56,716,000. FMR LLC boosted its stake in Tyra Biosciences by 0.8% in the 3rd quarter. FMR LLC now owns 3,372,850 shares of the company's stock worth $79,296,000 after buying an additional 26,187 shares during the last quarter. Boxer Capital Management LLC acquired a new stake in Tyra Biosciences in the 4th quarter worth about $28,185,000. Finally, Janus Henderson Group PLC boosted its stake in Tyra Biosciences by 63.6% in the 4th quarter. Janus Henderson Group PLC now owns 1,746,320 shares of the company's stock worth $24,291,000 after buying an additional 679,124 shares during the last quarter. 84.14% of the stock is owned by institutional investors and hedge funds.
About Tyra Biosciences
(
Get Free Report)
Tyra Biosciences, Inc, a clinical-stage biotechnology company, develops precision medicines for fibroblast growth factor receptor (FGFR) biology in the United States. The company offers SNÅP, a precision medicine platform that enables drug design through iterative molecular snapshots to predict genetic alterations for developing therapies targeting oncology and genetically defined conditions.
See Also
Before you consider Tyra Biosciences, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Tyra Biosciences wasn't on the list.
While Tyra Biosciences currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
